Jakarta, December 18, 2024 – One of Indonesia’s leading pharmaceutical companies, PT Pyridam Farma Tbk, now known as PYFAGROUP, through its subsidiary PT Ethica Industri Farmasi, is addressing a key public health issue prioritized by the Indonesian government: supporting the health of pregnant women. To this end, PYFAGROUP is committed to providing education and conducting research and innovation in efforts to prevent hypertension experienced by mothers during pregnancy.
According to SRS Litbangkes (2016) on the website of the Indonesian Ministry of Health, pregnancy-induced hypertension is the leading cause of maternal mortality in Indonesia, reaching 33%. Pregnancy-induced hypertension is a condition where the mother experiences hypertension that she would not have experienced if not pregnant. Hypertension during pregnancy can cause serious complications, including the risk of miscarriage, premature birth, organ damage, and placental abruption (a condition where the placenta separates from the uterine wall).
Carlinda Nekawaty, Head of Medical Affairs at PYFAGROUP, stated that “Hypertension during pregnancy often occurs in the second or third trimester, but this can be prevented by adopting a healthy lifestyle, such as reducing salt intake during pregnancy, routinely attending antenatal check-ups at health facilities at least three times during pregnancy, consuming healthy foods and increasing protein, vegetable, and fruit intake, and regularly performing light exercise as recommended by a doctor.”
Carlinda also added that recommended nutrition for pregnant women to prevent hypertension includes consuming foods low in salt, high in fiber, and rich in nutrients such as potassium, which can be found in bananas, potatoes, and spinach; magnesium in vegetables, nuts, and seeds; and consuming foods rich in high protein.
In addition to nutritious food intake, light exercise such as prenatal yoga, walking, and swimming can help improve blood circulation and maintain stable blood pressure to prevent hypertension during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) recommends pregnant women exercise for at least 30 minutes a day during pregnancy, with light to moderate intensity.
As part of its commitment to public health, PYFAGROUP is currently conducting research to develop medical solutions that can help prevent hypertension during pregnancy. This research focuses on the development of products and drug innovations that are safe for both mother and fetus.
“We believe that the health of pregnant women is an investment in the nation’s future. Therefore, we are not only committed to providing high-quality health products, but also raising public awareness through health education,” said Merciana Evy Iswari, President Director of PT Ethica Industri Farmasi.
Through these steps, PT Ethica Industri Farmasi continues to strive to create a positive impact on the health of pregnant women in Indonesia. With continuous education and medical innovation, it is hoped that maternal and infant mortality rates due to hypertension during pregnancy can be significantly reduced.
About PYFA
PT Pyridam Farma Tbk (“PYFA”) is one of the public companies in the pharmaceutical sector and is listed on the Indonesian Stock Exchange (Stock Code: PYFA) with business units in prescription drugs in various preparations such as tablets, capsules, creams, and injections. PYFA has well-known subsidiaries, including PT Holi Pharma, PT Ethica Industri Farmasi, and Probiotec Pty Ltd.
About PT Ethica Industri Farmasi
PT Ethica Industri Farmasi, which has been established since 1946, is one of the controlled subsidiaries of PT Pyridam Farma Tbk (“PYFA”) since 2023. PT Ethica Industri Farmasi has a business unit for prescription drugs in injection form.
Media Relations:
Leilanie Nadia Kusuma
Website: www.pyfa.co.id
Email: corcomm@pyfa.co.id
